- Home
- KOD vs FCBC Comparison
KOD vs FCBC Comparison
Compare KOD & FCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- FCBC
- Stock Information
- Founded
- KOD 2009
- FCBC 1874
- Country
- KOD United States
- FCBC United States
- Employees
- KOD N/A
- FCBC N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- FCBC Major Banks
- Sector
- KOD Health Care
- FCBC Finance
- Exchange
- KOD Nasdaq
- FCBC Nasdaq
- Market Cap
- KOD 795.5M
- FCBC 696.3M
- IPO Year
- KOD 2018
- FCBC 1992
- Fundamental
- Price
- KOD $14.09
- FCBC $34.08
- Analyst Decision
- KOD Buy
- FCBC
- Analyst Count
- KOD 6
- FCBC 0
- Target Price
- KOD $14.33
- FCBC N/A
- AVG Volume (30 Days)
- KOD 1.0M
- FCBC 44.5K
- Earning Date
- KOD 11-13-2025
- FCBC 10-24-2025
- Dividend Yield
- KOD N/A
- FCBC 3.65%
- EPS Growth
- KOD N/A
- FCBC N/A
- EPS
- KOD N/A
- FCBC 2.72
- Revenue
- KOD N/A
- FCBC $162,762,000.00
- Revenue This Year
- KOD N/A
- FCBC $2.27
- Revenue Next Year
- KOD N/A
- FCBC $11.13
- P/E Ratio
- KOD N/A
- FCBC $12.46
- Revenue Growth
- KOD N/A
- FCBC N/A
- 52 Week Low
- KOD $1.92
- FCBC $32.81
- 52 Week High
- KOD $19.39
- FCBC $49.02
- Technical
- Relative Strength Index (RSI)
- KOD 56.85
- FCBC 30.18
- Support Level
- KOD $13.91
- FCBC $33.91
- Resistance Level
- KOD $17.12
- FCBC $34.86
- Average True Range (ATR)
- KOD 2.04
- FCBC 0.76
- MACD
- KOD -0.13
- FCBC -0.20
- Stochastic Oscillator
- KOD 46.80
- FCBC 0.00
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.